Loading…

miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma

The prognosis of patients with metastatic rhabdomyosarcoma (RMS), the most common type of soft tissue sarcoma in children, is poor and no strategies have been identified to improve their dismal prognosis. Alpha-9 integrin (ITGA9) plays a particularly crucial role in cancer progression and invasivene...

Full description

Saved in:
Bibliographic Details
Published in:Cancer letters 2020-05, Vol.477, p.49-59
Main Authors: Molist, C., Navarro, N., Giralt, I., Zarzosa, P., Gallo-Oller, G., Pons, G., Magdaleno, A., Moreno, L., Guillén, G., Hladun, R., Garrido, M., Soriano, A., Segura, M.F., Sánchez de Toledo, J., Gallego, S., Roma, J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753
cites cdi_FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753
container_end_page 59
container_issue
container_start_page 49
container_title Cancer letters
container_volume 477
creator Molist, C.
Navarro, N.
Giralt, I.
Zarzosa, P.
Gallo-Oller, G.
Pons, G.
Magdaleno, A.
Moreno, L.
Guillén, G.
Hladun, R.
Garrido, M.
Soriano, A.
Segura, M.F.
Sánchez de Toledo, J.
Gallego, S.
Roma, J.
description The prognosis of patients with metastatic rhabdomyosarcoma (RMS), the most common type of soft tissue sarcoma in children, is poor and no strategies have been identified to improve their dismal prognosis. Alpha-9 integrin (ITGA9) plays a particularly crucial role in cancer progression and invasiveness. Despite the consensus on the remarkable pro-oncogenic potential of this protein, the miRNA-mediated regulation of ITGA9 has barely been studied to date. In the present study, miR-7 and miR-324-5p were selected as the best candidates after a screening to find ITGA9 regulators, and their effects on cell proliferation and invasion in RMS are described and characterized for the first time. Interestingly, the overexpression of both miRNA produced a clear impairment of cell proliferation, while miR-7 also induced a remarkable drop in cell invasion. Furthermore, the stable overexpression of both miRNA was found to reduce tumor growth in orthotopic RMS models and miR-7 was able to impair metastatic lung colonization. Consequently, we conclude that miR-7 and miR-324-5p show anti-oncogenic and anti-metastatic potential, thereby opening up the possibility of being used as novel therapeutic tools to avoid RMS progression. [Display omitted] •miR-7 and miR-324-5p are described for the first time as ITGA9 regulators in RMS.•miR-7 and miR-324-5p have a clear role in cell proliferation.•miR-7 has a crucial role in cell invasion, both in vitro and in vivo.•The animal models provided confirms a crucial in vivo role of both miRNA.
doi_str_mv 10.1016/j.canlet.2020.02.035
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2374316628</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S030438352030104X</els_id><sourcerecordid>2374316628</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753</originalsourceid><addsrcrecordid>eNp9kUtr3TAQRkVpaG7T_oNSDN10I0dPW9oUQugjEBoI7VrI8vhGF1tyJDsk_766ddpFF11pBs43GuYg9I6SmhLanB9qZ8MIS80IIzVhNeHyBdpR1TLcakVeoh3hRGCuuDxFr3M-EEKkaOUrdMoZFUxTvUP3k7_9foHbyoa-2mrOBJZzlWC_jnaByo7zndX4KiywTz5U8DgnyNnH8DsEj5CWUi0ex-DiHoJ3FQwDuCVXBU93tuvj9BSzTS5O9g06GeyY4e3ze4Z-fvn84_Ibvr75enV5cY2dEHTBumENER1o55xyTHW0c7xrOmYHUL3r5dBKsJY5wbXUx6ZjLVCQDVV9afkZ-rjNnVO8XyEvZvLZwTjaAHHNhvFWcNo0TBX0wz_oIa4plO0ME0w2SmjKCyU2yqWYc4LBzMlPNj0ZSsxRiTmYTYk5KjGEmaKkxN4_D1-7Cfq_oT8OCvBpA6Bc48FDMtl5CA56n8oRTR_9_3_4BRoEnoE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425684913</pqid></control><display><type>article</type><title>miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Molist, C. ; Navarro, N. ; Giralt, I. ; Zarzosa, P. ; Gallo-Oller, G. ; Pons, G. ; Magdaleno, A. ; Moreno, L. ; Guillén, G. ; Hladun, R. ; Garrido, M. ; Soriano, A. ; Segura, M.F. ; Sánchez de Toledo, J. ; Gallego, S. ; Roma, J.</creator><creatorcontrib>Molist, C. ; Navarro, N. ; Giralt, I. ; Zarzosa, P. ; Gallo-Oller, G. ; Pons, G. ; Magdaleno, A. ; Moreno, L. ; Guillén, G. ; Hladun, R. ; Garrido, M. ; Soriano, A. ; Segura, M.F. ; Sánchez de Toledo, J. ; Gallego, S. ; Roma, J.</creatorcontrib><description>The prognosis of patients with metastatic rhabdomyosarcoma (RMS), the most common type of soft tissue sarcoma in children, is poor and no strategies have been identified to improve their dismal prognosis. Alpha-9 integrin (ITGA9) plays a particularly crucial role in cancer progression and invasiveness. Despite the consensus on the remarkable pro-oncogenic potential of this protein, the miRNA-mediated regulation of ITGA9 has barely been studied to date. In the present study, miR-7 and miR-324-5p were selected as the best candidates after a screening to find ITGA9 regulators, and their effects on cell proliferation and invasion in RMS are described and characterized for the first time. Interestingly, the overexpression of both miRNA produced a clear impairment of cell proliferation, while miR-7 also induced a remarkable drop in cell invasion. Furthermore, the stable overexpression of both miRNA was found to reduce tumor growth in orthotopic RMS models and miR-7 was able to impair metastatic lung colonization. Consequently, we conclude that miR-7 and miR-324-5p show anti-oncogenic and anti-metastatic potential, thereby opening up the possibility of being used as novel therapeutic tools to avoid RMS progression. [Display omitted] •miR-7 and miR-324-5p are described for the first time as ITGA9 regulators in RMS.•miR-7 and miR-324-5p have a clear role in cell proliferation.•miR-7 has a crucial role in cell invasion, both in vitro and in vivo.•The animal models provided confirms a crucial in vivo role of both miRNA.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2020.02.035</identifier><identifier>PMID: 32142919</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Adapter proteins ; Animals ; Antibodies ; Brain cancer ; Cell adhesion &amp; migration ; Cell Line, Tumor ; Cell proliferation ; Cell Proliferation - genetics ; Chromosomes ; Cloning ; Colonization ; Doxycycline - pharmacology ; Focal Adhesion Kinase 1 - genetics ; Focal Adhesion Kinase 1 - metabolism ; Gene Expression Regulation, Neoplastic ; Humans ; Integrins ; Integrins - genetics ; Invasiveness ; ITGA9 ; Kinases ; Laboratories ; Ligands ; Medical prognosis ; Melanoma ; Metastases ; Metastasis ; Mice, SCID ; MicroRNAs ; MicroRNAs - genetics ; miRNA ; Pediatric cancer ; Pediatrics ; Phosphorylation ; Prognosis ; Rhabdomyosarcoma ; Rhabdomyosarcoma - drug therapy ; Rhabdomyosarcoma - genetics ; Rhabdomyosarcoma - pathology ; RNA, Small Interfering ; Soft tissue sarcoma ; Xenograft Model Antitumor Assays</subject><ispartof>Cancer letters, 2020-05, Vol.477, p.49-59</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><rights>2020. Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753</citedby><cites>FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32142919$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Molist, C.</creatorcontrib><creatorcontrib>Navarro, N.</creatorcontrib><creatorcontrib>Giralt, I.</creatorcontrib><creatorcontrib>Zarzosa, P.</creatorcontrib><creatorcontrib>Gallo-Oller, G.</creatorcontrib><creatorcontrib>Pons, G.</creatorcontrib><creatorcontrib>Magdaleno, A.</creatorcontrib><creatorcontrib>Moreno, L.</creatorcontrib><creatorcontrib>Guillén, G.</creatorcontrib><creatorcontrib>Hladun, R.</creatorcontrib><creatorcontrib>Garrido, M.</creatorcontrib><creatorcontrib>Soriano, A.</creatorcontrib><creatorcontrib>Segura, M.F.</creatorcontrib><creatorcontrib>Sánchez de Toledo, J.</creatorcontrib><creatorcontrib>Gallego, S.</creatorcontrib><creatorcontrib>Roma, J.</creatorcontrib><title>miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>The prognosis of patients with metastatic rhabdomyosarcoma (RMS), the most common type of soft tissue sarcoma in children, is poor and no strategies have been identified to improve their dismal prognosis. Alpha-9 integrin (ITGA9) plays a particularly crucial role in cancer progression and invasiveness. Despite the consensus on the remarkable pro-oncogenic potential of this protein, the miRNA-mediated regulation of ITGA9 has barely been studied to date. In the present study, miR-7 and miR-324-5p were selected as the best candidates after a screening to find ITGA9 regulators, and their effects on cell proliferation and invasion in RMS are described and characterized for the first time. Interestingly, the overexpression of both miRNA produced a clear impairment of cell proliferation, while miR-7 also induced a remarkable drop in cell invasion. Furthermore, the stable overexpression of both miRNA was found to reduce tumor growth in orthotopic RMS models and miR-7 was able to impair metastatic lung colonization. Consequently, we conclude that miR-7 and miR-324-5p show anti-oncogenic and anti-metastatic potential, thereby opening up the possibility of being used as novel therapeutic tools to avoid RMS progression. [Display omitted] •miR-7 and miR-324-5p are described for the first time as ITGA9 regulators in RMS.•miR-7 and miR-324-5p have a clear role in cell proliferation.•miR-7 has a crucial role in cell invasion, both in vitro and in vivo.•The animal models provided confirms a crucial in vivo role of both miRNA.</description><subject>Adapter proteins</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Brain cancer</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell Line, Tumor</subject><subject>Cell proliferation</subject><subject>Cell Proliferation - genetics</subject><subject>Chromosomes</subject><subject>Cloning</subject><subject>Colonization</subject><subject>Doxycycline - pharmacology</subject><subject>Focal Adhesion Kinase 1 - genetics</subject><subject>Focal Adhesion Kinase 1 - metabolism</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Integrins</subject><subject>Integrins - genetics</subject><subject>Invasiveness</subject><subject>ITGA9</subject><subject>Kinases</subject><subject>Laboratories</subject><subject>Ligands</subject><subject>Medical prognosis</subject><subject>Melanoma</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Mice, SCID</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>miRNA</subject><subject>Pediatric cancer</subject><subject>Pediatrics</subject><subject>Phosphorylation</subject><subject>Prognosis</subject><subject>Rhabdomyosarcoma</subject><subject>Rhabdomyosarcoma - drug therapy</subject><subject>Rhabdomyosarcoma - genetics</subject><subject>Rhabdomyosarcoma - pathology</subject><subject>RNA, Small Interfering</subject><subject>Soft tissue sarcoma</subject><subject>Xenograft Model Antitumor Assays</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kUtr3TAQRkVpaG7T_oNSDN10I0dPW9oUQugjEBoI7VrI8vhGF1tyJDsk_766ddpFF11pBs43GuYg9I6SmhLanB9qZ8MIS80IIzVhNeHyBdpR1TLcakVeoh3hRGCuuDxFr3M-EEKkaOUrdMoZFUxTvUP3k7_9foHbyoa-2mrOBJZzlWC_jnaByo7zndX4KiywTz5U8DgnyNnH8DsEj5CWUi0ex-DiHoJ3FQwDuCVXBU93tuvj9BSzTS5O9g06GeyY4e3ze4Z-fvn84_Ibvr75enV5cY2dEHTBumENER1o55xyTHW0c7xrOmYHUL3r5dBKsJY5wbXUx6ZjLVCQDVV9afkZ-rjNnVO8XyEvZvLZwTjaAHHNhvFWcNo0TBX0wz_oIa4plO0ME0w2SmjKCyU2yqWYc4LBzMlPNj0ZSsxRiTmYTYk5KjGEmaKkxN4_D1-7Cfq_oT8OCvBpA6Bc48FDMtl5CA56n8oRTR_9_3_4BRoEnoE</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Molist, C.</creator><creator>Navarro, N.</creator><creator>Giralt, I.</creator><creator>Zarzosa, P.</creator><creator>Gallo-Oller, G.</creator><creator>Pons, G.</creator><creator>Magdaleno, A.</creator><creator>Moreno, L.</creator><creator>Guillén, G.</creator><creator>Hladun, R.</creator><creator>Garrido, M.</creator><creator>Soriano, A.</creator><creator>Segura, M.F.</creator><creator>Sánchez de Toledo, J.</creator><creator>Gallego, S.</creator><creator>Roma, J.</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20200501</creationdate><title>miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma</title><author>Molist, C. ; Navarro, N. ; Giralt, I. ; Zarzosa, P. ; Gallo-Oller, G. ; Pons, G. ; Magdaleno, A. ; Moreno, L. ; Guillén, G. ; Hladun, R. ; Garrido, M. ; Soriano, A. ; Segura, M.F. ; Sánchez de Toledo, J. ; Gallego, S. ; Roma, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adapter proteins</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Brain cancer</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell Line, Tumor</topic><topic>Cell proliferation</topic><topic>Cell Proliferation - genetics</topic><topic>Chromosomes</topic><topic>Cloning</topic><topic>Colonization</topic><topic>Doxycycline - pharmacology</topic><topic>Focal Adhesion Kinase 1 - genetics</topic><topic>Focal Adhesion Kinase 1 - metabolism</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Integrins</topic><topic>Integrins - genetics</topic><topic>Invasiveness</topic><topic>ITGA9</topic><topic>Kinases</topic><topic>Laboratories</topic><topic>Ligands</topic><topic>Medical prognosis</topic><topic>Melanoma</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Mice, SCID</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>miRNA</topic><topic>Pediatric cancer</topic><topic>Pediatrics</topic><topic>Phosphorylation</topic><topic>Prognosis</topic><topic>Rhabdomyosarcoma</topic><topic>Rhabdomyosarcoma - drug therapy</topic><topic>Rhabdomyosarcoma - genetics</topic><topic>Rhabdomyosarcoma - pathology</topic><topic>RNA, Small Interfering</topic><topic>Soft tissue sarcoma</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Molist, C.</creatorcontrib><creatorcontrib>Navarro, N.</creatorcontrib><creatorcontrib>Giralt, I.</creatorcontrib><creatorcontrib>Zarzosa, P.</creatorcontrib><creatorcontrib>Gallo-Oller, G.</creatorcontrib><creatorcontrib>Pons, G.</creatorcontrib><creatorcontrib>Magdaleno, A.</creatorcontrib><creatorcontrib>Moreno, L.</creatorcontrib><creatorcontrib>Guillén, G.</creatorcontrib><creatorcontrib>Hladun, R.</creatorcontrib><creatorcontrib>Garrido, M.</creatorcontrib><creatorcontrib>Soriano, A.</creatorcontrib><creatorcontrib>Segura, M.F.</creatorcontrib><creatorcontrib>Sánchez de Toledo, J.</creatorcontrib><creatorcontrib>Gallego, S.</creatorcontrib><creatorcontrib>Roma, J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Molist, C.</au><au>Navarro, N.</au><au>Giralt, I.</au><au>Zarzosa, P.</au><au>Gallo-Oller, G.</au><au>Pons, G.</au><au>Magdaleno, A.</au><au>Moreno, L.</au><au>Guillén, G.</au><au>Hladun, R.</au><au>Garrido, M.</au><au>Soriano, A.</au><au>Segura, M.F.</au><au>Sánchez de Toledo, J.</au><au>Gallego, S.</au><au>Roma, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2020-05-01</date><risdate>2020</risdate><volume>477</volume><spage>49</spage><epage>59</epage><pages>49-59</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>The prognosis of patients with metastatic rhabdomyosarcoma (RMS), the most common type of soft tissue sarcoma in children, is poor and no strategies have been identified to improve their dismal prognosis. Alpha-9 integrin (ITGA9) plays a particularly crucial role in cancer progression and invasiveness. Despite the consensus on the remarkable pro-oncogenic potential of this protein, the miRNA-mediated regulation of ITGA9 has barely been studied to date. In the present study, miR-7 and miR-324-5p were selected as the best candidates after a screening to find ITGA9 regulators, and their effects on cell proliferation and invasion in RMS are described and characterized for the first time. Interestingly, the overexpression of both miRNA produced a clear impairment of cell proliferation, while miR-7 also induced a remarkable drop in cell invasion. Furthermore, the stable overexpression of both miRNA was found to reduce tumor growth in orthotopic RMS models and miR-7 was able to impair metastatic lung colonization. Consequently, we conclude that miR-7 and miR-324-5p show anti-oncogenic and anti-metastatic potential, thereby opening up the possibility of being used as novel therapeutic tools to avoid RMS progression. [Display omitted] •miR-7 and miR-324-5p are described for the first time as ITGA9 regulators in RMS.•miR-7 and miR-324-5p have a clear role in cell proliferation.•miR-7 has a crucial role in cell invasion, both in vitro and in vivo.•The animal models provided confirms a crucial in vivo role of both miRNA.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>32142919</pmid><doi>10.1016/j.canlet.2020.02.035</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2020-05, Vol.477, p.49-59
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_2374316628
source ScienceDirect Freedom Collection 2022-2024
subjects Adapter proteins
Animals
Antibodies
Brain cancer
Cell adhesion & migration
Cell Line, Tumor
Cell proliferation
Cell Proliferation - genetics
Chromosomes
Cloning
Colonization
Doxycycline - pharmacology
Focal Adhesion Kinase 1 - genetics
Focal Adhesion Kinase 1 - metabolism
Gene Expression Regulation, Neoplastic
Humans
Integrins
Integrins - genetics
Invasiveness
ITGA9
Kinases
Laboratories
Ligands
Medical prognosis
Melanoma
Metastases
Metastasis
Mice, SCID
MicroRNAs
MicroRNAs - genetics
miRNA
Pediatric cancer
Pediatrics
Phosphorylation
Prognosis
Rhabdomyosarcoma
Rhabdomyosarcoma - drug therapy
Rhabdomyosarcoma - genetics
Rhabdomyosarcoma - pathology
RNA, Small Interfering
Soft tissue sarcoma
Xenograft Model Antitumor Assays
title miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A02%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miRNA-7%20and%20miRNA-324-5p%20regulate%20alpha9-Integrin%20expression%20and%20exert%20anti-oncogenic%20effects%20in%20rhabdomyosarcoma&rft.jtitle=Cancer%20letters&rft.au=Molist,%20C.&rft.date=2020-05-01&rft.volume=477&rft.spage=49&rft.epage=59&rft.pages=49-59&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2020.02.035&rft_dat=%3Cproquest_cross%3E2374316628%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-962604be9ccc8c28b1bc3b6b2afe8dcd5f75eaa2c43959f75eb27e1e5618df753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2425684913&rft_id=info:pmid/32142919&rfr_iscdi=true